JASON SWIECKI: Open Payments
NPI 1013763416 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 31 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $263 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $103 |
| SHIELD THERAPEUTICS INC | 3 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| PFIZER INC. | 3 | $66 |
| ABBVIE INC. | 2 | $56 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| ABIOMED | 1 | $29 |
Products named: ACCRUFER, Kerendia, Ozempic, VRAYLAR, TRELEGY ELLIPTA, JARDIANCE, PREVNAR 20, Auvelity.
Industry payments across CA — which companies pay providers there.
